Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06065150
Other study ID # 2023-A00875-40
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2, 2024
Est. completion date January 1, 2028

Study information

Verified date August 2023
Source University Hospital, Angers
Contact Paul Le Naoures, Dr
Phone (0)2 41 35 49 16
Email Paul.LeNaoures@chu-angers.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For uncomplicated acute small bowel obstruction (aSBO), the "Bologna guidelines" recommend non-surgical management of 72 hours before considering surgery. This treatment is based on the placement of a nasogastric tube and the correction of hydro-electrolyte disorders. Non-surgical management is only effective in 60 to 70% and surgery is therefore necessary in 30 to 40% of cases after medical treatment for at least 3 days. This therefore leads to an increase in the length of hospital stay. Some authors also point out that postponing surgery for 3 days would aggravate the morbidity and mortality of surgery. Indeed, aSBO surgery has a complication rate of 10-40% and a mortality of up to 4%. There is a lack of studies evaluating what is the best management strategy for aSBO, especially with regard to the duration of medical treatment. Many recent studies plead in favor of early surgical treatment (<24 hours) which would reduce the morbidity and mortality rate of surgery but also the overall cost of treatment by reducing the length of stay. This paradigm shift is linked to the improvement of anesthetic and intensive care management over the last few years, but also to the advent of laparoscopy in emergency surgery. Indeed, laparoscopy could reduce the duration of hospitalization but also the operative morbidity and mortality. However, this surgical approach is not feasible in all situations and the conversion rate is reported in 30 to 76% of cases. One of the factors favoring the feasibility of the laparoscopic approach is the performance of early surgery. Another parameter favoring the feasibility of the laparoscopic approach is the aSBO mechanism: an aSBO on flange (SBA) is more likely to be treated effectively by laparoscopic than an aSBO on multiple adhesions (MA). In the literature, there is little to differentiate SBAs from MAs. Advances in CT scans have made it possible to describe the signs associated with the SBA mechanism and then to propose a score making it possible to predict the SBA mechanism with good performance (sensitivity 67.6%, specificity 84.6%). This score not only has the advantage of predicting the mechanism of the occlusion but it also makes it possible to predict the failure of non-surgical treatment if the score is ≥5.


Description:

Multicentre randomized open-label controlled trial. Patients admitted to visceral surgery for aSBO are screened and the study is offered for patients who do not meet the criteria for emergency surgery. If they accept the study, a randomization is carried out by stratification according to (i) the sex, (ii) the center (University hospital/ Peripheral center), (iii) the number of previous episodes of aSBO (0 or ≥1 ) and the value of the radiological score (< or ≥5). Patients are cared for according to the strategy defined by randomisation (standard procedure vs early surgery proposed according to the radiological score). Demographic information, medical and surgical history, and treatments are collected on the day of admission. A visit is made each day (from admission to discharge) to collect information on the surgery (if performed), on the medical management and its success or failure (if applicable), on the recovery of functions gastrointestinal, on perioperative management, on morbidity and mortality. Patients have a follow-up consultation on D30 and D90 postoperative. Any morbidity, mortality or recurrence that occurred during this period is collected. Patients are contacted by telephone after 12 months to ensure that no recurrence of aSBO has occurred.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 630
Est. completion date January 1, 2028
Est. primary completion date January 1, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Admission for acute intestinal obstruction of the small intestine on adhesion or bridle - Confirmation of the aSBO by a scanner - Adult patient - Beneficiary of a social security scheme - Having signed an informed consent Exclusion Criteria: - Indication for urgent surgery (small intestine ischemia, intestinal pain, defence, hemodynamic shock, etc.) - Pregnancy or breastfeeding - Poor understanding of the French language - Person deprived of liberty by judicial or administrative decision - Person undergoing psychiatric treatment under duress - Person subject to a legal protection measure - Person unable to express consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Standard support
See arm/group descriptions
Early surgery proposed according to the radiological score
If score = 5: the risk of medical treatment failure is multiplied by 2.9 (Feuerstoss F et al, J Gastrointest Surg 2021). Early surgical treatment is proposed; that is, the procedure is performed within 24 hours of admission. The surgery is initiated by laparoscopy and converted to open surgery if necessary. If score < 5: the risk of medical treatment failure is reduced. Initial medical treatment is therefore offered in accordance with standard management.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Angers Direction Générale de l'Offre de Soins

Outcome

Type Measure Description Time frame Safety issue
Primary 90-day morbidity and mortality of aSBO management using the radiological score The main objective is to evaluate the effectiveness, in terms of 90-day morbidity and mortality, of management of uncomplicated aSBO based on the use of the radiological score as a tool to select patients eligible for early surgery. compared to standard care (medical treatment for 72 hours). 90 days
Secondary Morbidity and mortality at 30 days Morbidity and mortality at 30 days of aSBO management 30 days
Secondary Length of patient hospitalization Time between admission and discharge from hospitalization assessed to 2 days
Secondary Recurrence rate of aSBO Recurrence rate of aSBO after the episode. Recurrence is defined by any admission of the patient for nausea/vomiting and absence of flatulence and stools with a CT scan showing distension of the small intestine within one year of admission. one year
Secondary Rate of recourse to surgery for patients not operated on straight away Recourse to surgery is defined by a surgical intervention carried out for the treatment of aSBO One year
Secondary Surgical morbidity and mortality at 30 days of patients operated on during the first hospitalization Surgical morbidity and mortality at 30 days of aSBO management defined as the appearance of a deviation from the normal course of expected surgical outcomes between the day of hospitalization and the 30th day. Morbi-mortality is classified according to the Dindo-Clavien scale. Morbi-mortality is collected only for surgical patients, and if the episode is secondary to surgical treatment. 30 days
Secondary Laparoscopic surgery rate Laparoscopic surgery rate is defined as the number of surgeries performed from incision to closure by laparoscopic approach out of the total number of surgeries. The need for conversion by laparotomy will also be collected and compared between the 2 groups Surgery time assessed to 1 hour
See also
  Status Clinical Trial Phase
Completed NCT02065661 - Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator) N/A
Completed NCT05517057 - Radiologic Score and Failure of Conservative Management of Adhesive Small Bowel Obstruction
Not yet recruiting NCT05864378 - POCUS for Small Bowel Obstruction in the ED: a Retrospective Study
Terminated NCT03573921 - Gastrografin for Treating Small Bowel Obstruction in Children Phase 2/Phase 3
Recruiting NCT05315765 - Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
Not yet recruiting NCT01934283 - Intrabdominal Pressure in Small Bowel Obstruction as a Possible Predictor for the Need of Operation N/A
Not yet recruiting NCT04001985 - Nasogastric Tube Clamping Trial vs. Immediate Removal N/A
Enrolling by invitation NCT05878015 - A Study of Intravenous Acetaminophen for Small Bowel Obstruction Phase 4
Recruiting NCT03139149 - Comparison of Early Operative Treatment and 48 h Conservative Treatment in Small Bowel Obstruction N/A
Active, not recruiting NCT06101719 - Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction
Completed NCT00389116 - Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction Phase 4
Not yet recruiting NCT05843097 - SnapSBO - Small Bowel Obstruction Snapshot Audit
Completed NCT05662384 - Small Bowel Obstruction. A Prospective Multicener Study
Completed NCT04929275 - Enhanced Recovery Programs and Small Bowel Obstruction N/A
Not yet recruiting NCT06140173 - Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction N/A
Completed NCT01082627 - Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel Obstruction Phase 4
Completed NCT03461744 - Diagnostic Scoring for Small Bowel Obstruction
Completed NCT02190981 - Point of Care Ultrasound for Suspected Small Bowel Obstruction in the Emergency Department
Completed NCT01524081 - Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures Phase 3
Completed NCT03386136 - Therapeutic Oxygen for Gastrointestinal Atony (TOGA) Phase 1